(500 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma ManagementThe European Academy of Allergy and Clinical Immunology (EAACI) have designed a short onli...
-
Launch of the PAI Virtual Issue on Asthma & EnvironmentIn an effort to further elucidate the environmental factors that are central to our unders...
-
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animalsAbstract Adverse reactions to insects occur in both human and veterinary patients. System...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityAbstract Immediate and nonimmediate hypersensitivity reactions to iodinated contrast medi...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position PaperAbstract Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT16...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria TaskforceAbstract Background: Although well described in adults, there are scarce and heterogene...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives - A report of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract With the worldwide spread of the novel severe acute respiratory syndrome coronav...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendationsAbstract Immune modulation is a key therapeutic approach for allergic diseases, asthma an...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic studyAbstract Research data derived from observational studies are accumulating quickly in the...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2Abstract The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the se...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position PaperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescentsAbstract Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatri...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesAbstract The first approved COVID-19 vaccines include Pfizer/BioNTech BNT162B2, Moderna m...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence NetworkAllergy, Asthma and Clinical Immunology Research has many challenges, including complex Eu...
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - An EAACI Task Force ReportAbstract Background: The effectiveness of allergen immunotherapy (AIT) in seasonal and ...
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperAbstract Background: Food anaphylaxis is commonly elicited by unintentional ingestion o...
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paperAbstract NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflamm...
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paperAbstract Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a n...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
Show more Position Papers (77)Show Less-
-
Role Viral reactivations
-
BAT in clinical practice. Is it possible?
-
Anaphylaxis in ICD-11
-
Novel pharamacological targets
-
Hypereosinophilic syndromes and autoimmunity
-
Tackling anaphylaxis
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Immunological basis of food aversion
-
Structural biology of food allergens and cross reactivity
-
Viral infection and asthma
-
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
-
The clinical clues and pitfalls in contact dermatitis
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Hypersensitivity to antiepileptic drugs
-
Differential diagnosis
-
Air pollution and allergy: call for action!
-
The dilemma of food allergy additives
-
Hologenome and obesity
-
AIT, Biologicals and Covid vaccination
-
Asma e alergia em pandemia
-
Launch of the Biological guidelines
-
Oral food challenges thresholds for clinical reactions
-
AIT in the pediatric population
-
Collective advocacy for action on CRDs
-
Unusual presentations of contact dermatitis
-
Immune modulation in local allergic rhinitis
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Difficult to control asthma in adults
-
Eosinophilic fasciitis, an unusual presentation
-
Preparing a grant: Dos and Don'ts
-
Should we do patch testing in children with eczema?
-
Epithelial cell barrier and allergic diseases
-
AAAAI Practice Parameters
-
What is the immunological basis for new biologicals?
-
Global impact of the COVID-19 on the environment
-
E-cigarettes: mechanistic link to lung injury
-
Nasal allergen challenge
-
Risk assessment and active management of food allergy
-
New perspectives for anaphylaxis
-
Impacting quality of life with PALFORZIA
-
Molecular allergology in daily clinical practice
-
Phenotypes and endotypes of occupational allergy
-
Bronchial allergen challenge in the clinic
-
Big data and cluster analysis: a real life perspective
-
The basics of severe asthma - biomarkers
-
Dupilumab (anti-IL4Ra) in CRSwNP
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Exercise: induced asthma and rhinitis
-
Difficult to control asthma in children
-
Precision medicine and biomarkers of atopic dermatitis
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Updates in [severe] asthma in adults
-
Tezepelumab (anti-TSLP) in asthma
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Lung function testing
-
Is anaphylaxis really rare in children?
-
Update of the WAO anaphylaxis guidance
-
New and clinically relevant contact allergens
-
Novel approaches of allergen immunotherapy
-
Exercise-induced urticaria and anaphylaxis
-
Current and future perspectives
-
Adherence: A challenge for Immunotherapy
-
Do adrenaline auto-injectors save lives?
-
Environmental epigenomics of allergy
-
Big Data Analysis: MetabolomicsView Presentation
-
Elderly asthma
-
Recognizing immediate reactions in contact dermatitis
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Virtual care, social media and mHealth for allergy management
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
Bronchial allergen challenge in research
-
It looks like urticaria – but is it?
-
Early biomarkers for severe drug hypersensitivity reactions
-
An update on food allergy
-
Current status on prophylaxis in HAE
-
Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs – is it useful?
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
How to improve outcomes
-
Measles infection causes immune amnesia
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Predicting adverse reactions to biologicals
-
Update on drug allergy
-
Asma e alergia em Angola
-
Neuroimmunology and allergy
-
When hives are not chronic urticaria
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
Over-the-counter allergy prevention weaning products
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Cellular tests for the diagnosing and monitoring of allergy
-
Autoimmunity in atopic diseases
-
Precision Medicine and AIT
-
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
-
Food industry perspective
-
Skin care from birth for allergy prevention: results today
-
Precision medicine in immunodeficiency
-
How to use social media in your professional practice: the clinician perspective
-
Delabelling adults
-
Social media and Allergies: how can we support our patients?
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Primary care in CRDs during COVID
-
A system biology and machine learning approach to childhood asthma
-
Living with food allergy
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Bronchiectasis and severe asthma
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Mental health needs and access to care among patients with food allergy
-
Impact of climate change on the immune system
-
Chronic rhinosinusitis with nasal polyps
-
Impaired olfaction: diagnostics and its role in diseases
-
EAACI Guidelines on environmental health
-
Telemedicine and Tele-health
-
Management of adverse reactions to biologics
-
New insights in urticaria mechanisms
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Unmet needs in immunological mechanisms in AIT: key cellular playersView Presentation
-
How to evaluate lung function? Hands-on plus lecture
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Innate trained immunity: An evolutionary perspective
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
The brain, nose, immune axis
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
How to select and follow a biological for asthma and CRSwNP
-
Big changes in asthma treatment : GINA 2019
-
Late onset T2 asthma – a case study
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
The engineering-medicine interface
-
Allergen immunotherapy for rhinitis phenotypes other than allergic rhinitis: mixed rhinitis and local allergic rhinitis
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Therapies for multiple-tree nut allergies
-
Urban green spaces - The exposure and allergenicity index
-
How to keep a child with anaphylaxis safe in school
-
The ‘allergy tool kit’ for the transition clinic
-
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
-
How does Type 2 mucosal inflammation influence susceptibility to SARS-CoV-2?
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Challenges on the implementation of early introduction of allergenic foods
-
Biotin interference can cause false-negative IgE test results in patients with anaphylaxis
-
What’s different about the adolescent brain?
-
The role of infection in chronic spontaneous urticaria
-
Targeted approaches for asthma
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Developing an adolescent and young adult allergy service
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
Electronic Health in Severe Asthma
-
Basophil activation test results change in birch pollen sensitized patients during first season of immunotherapy
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Is IgA a piece of the EoE puzzle?
-
Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs
-
The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics
-
Molecular and structural considerations for aerosolization of food allergens
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis
-
Gut microbiome - based therapeutic approaches
-
Probiotics and prebiotics: an on-going journey
-
Potential biomarkers for diagnosis and treatment for CSU
-
Tree nut allergy: path from national to global data
-
Insight from translational research on oral tolerance induction through breast milk
-
Role of antigen-presenting cells in tolerance and allergy
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
GINA Guidelines Update
-
Occupational respiratory allergy in food processing industries
-
Assessing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) severity by JESREC algorithm
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
Does probiotic microorganism lactobacillus reuteri prevents allergic rhinitis and rhinoconjunctivitis development in children
-
How to improve compliance of allergen immunotherapy in the clinic?
-
B cells in in chronic rhinosinusitis: friend or foe
-
Psychological support to peanut allergic children and their families
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Siblings and atopy by living standard, period, and atopy assessment method: a systematic review and meta-analysis
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Assessment of adherence to treatment using mHealth
-
Characterization of the immunological properties of different β-glucans on myeloid dendritic cells
-
Desensitization in chemotherapy and biologics
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
Immunotherapy in severe asthma (AIT)
-
Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients
-
Inflammatory biomarkers
-
Wild-fires, pollution, climate change and other threats
-
Impact of climate change on asthma exacerbations
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
May contain traces… management in children with food allergies
-
A patient with an acute reaction: recognize, document and treat
-
How do allergens sensitize?
-
Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Fecal transplantation: a safe and efficient treatment option for gut dysbiosis? (Pro & Con Session: Con)
-
Fecal transplantation: a safe and efficient treatment option for gut dysbiosis? (Pro & Con Session: Pro)
-
Drug provocation test in non-immediate beta-lactam hypersensitivity workup: One-day vs prolonged protocol in pediatric patients
-
Focus on Patient. Personalised therapy for severe asthma
-
Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis
-
Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Outcome measures for adult’s vs children in the clinic during allergen immunotherapy
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Venom immunotherapy in predominant Api m 10 sensitization: Does it work?
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
Alternative free-from foods to reach a balanced diet
-
Mo
-